| 0.8 |
3.8 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.6 |
1.8 |
GO:0086055 |
atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.5 |
1.6 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.5 |
0.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 |
1.4 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.5 |
1.4 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.5 |
1.4 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.5 |
1.4 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.4 |
1.3 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.4 |
0.4 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.4 |
1.3 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.4 |
1.7 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.4 |
2.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.4 |
1.1 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.4 |
3.2 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 |
1.0 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.3 |
1.3 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.3 |
2.3 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
1.9 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.3 |
2.5 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.3 |
1.2 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.3 |
1.2 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 |
1.8 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 |
0.9 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.3 |
2.3 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.3 |
1.1 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.3 |
0.9 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.3 |
1.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 |
1.4 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
0.8 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.3 |
1.3 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.3 |
1.3 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.3 |
1.6 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 |
1.0 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 |
1.0 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.3 |
0.8 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.3 |
1.8 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.3 |
2.5 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.3 |
1.3 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 |
0.7 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.2 |
2.0 |
GO:0002005 |
angiotensin catabolic process in blood(GO:0002005) |
| 0.2 |
1.0 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.2 |
0.9 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.2 |
0.2 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.2 |
1.8 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 |
1.5 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.2 |
0.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
0.6 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 |
1.1 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.2 |
0.6 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) regulation of secretion of lysosomal enzymes(GO:0090182) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.2 |
0.8 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.2 |
1.2 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.2 |
1.0 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.2 |
3.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.2 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.2 |
0.4 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.2 |
0.6 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.2 |
0.6 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 |
0.8 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 |
0.6 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.2 |
7.9 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 |
1.0 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.2 |
0.8 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.2 |
0.8 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
0.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
0.8 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
0.6 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.2 |
1.3 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.2 |
0.6 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.2 |
0.2 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 |
0.7 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.6 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 |
1.8 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
0.5 |
GO:0045553 |
TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.2 |
0.9 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
0.5 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.2 |
1.4 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
0.7 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
5.8 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.2 |
1.2 |
GO:0002353 |
kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 |
0.2 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.2 |
0.2 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.2 |
0.5 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
1.0 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.2 |
0.9 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.2 |
4.6 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
0.7 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.2 |
1.0 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.2 |
0.2 |
GO:0008589 |
regulation of smoothened signaling pathway(GO:0008589) |
| 0.2 |
0.5 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.2 |
1.3 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 |
0.5 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.2 |
1.0 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
1.0 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.2 |
0.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.8 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.2 |
0.8 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
1.3 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
0.5 |
GO:2000612 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 |
0.8 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 |
0.3 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.2 |
2.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
2.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
0.8 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 |
0.3 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 |
0.1 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.1 |
0.6 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 |
0.4 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.1 |
0.4 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.1 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 0.1 |
0.4 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.3 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.4 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.4 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
0.6 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
1.5 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 |
0.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
2.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.4 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.7 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
3.8 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.4 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
0.4 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
2.3 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.4 |
GO:0045766 |
positive regulation of angiogenesis(GO:0045766) |
| 0.1 |
0.4 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 |
0.1 |
GO:2001076 |
thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.1 |
0.5 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.1 |
1.1 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.1 |
0.9 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.4 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.1 |
0.4 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.1 |
0.3 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 |
0.5 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.1 |
0.1 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 |
0.4 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.1 |
0.6 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.4 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.1 |
0.5 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.1 |
0.3 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 |
0.5 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.4 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
0.1 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.1 |
0.4 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
1.0 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
0.7 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.1 |
0.2 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.1 |
2.6 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 |
0.2 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.1 |
0.9 |
GO:2000538 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.1 |
0.2 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 |
0.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
0.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.4 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.1 |
2.9 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.2 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.5 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.6 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.8 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.8 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.3 |
GO:1903410 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.1 |
0.9 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 |
1.3 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.6 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.1 |
0.6 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 |
0.5 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
0.3 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.8 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 |
0.5 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 |
0.2 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.1 |
0.3 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.4 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
5.7 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.3 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.1 |
0.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
1.8 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.3 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.1 |
0.2 |
GO:1902725 |
negative regulation of satellite cell differentiation(GO:1902725) |
| 0.1 |
0.2 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.3 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 |
2.1 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.1 |
1.0 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
0.6 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.1 |
0.2 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.1 |
0.7 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.2 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.1 |
0.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.4 |
GO:0045209 |
MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 |
0.6 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 |
1.6 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
0.4 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
2.9 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.1 |
1.6 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
0.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.4 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.1 |
0.4 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
0.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.3 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.7 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.4 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
0.3 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.1 |
1.8 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.6 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.7 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
1.3 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.3 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.4 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
2.5 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.9 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
0.4 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 |
1.0 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.3 |
GO:0031052 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.1 |
0.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.3 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.1 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.1 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
1.1 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.1 |
1.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.1 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.1 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.1 |
0.1 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.1 |
0.9 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.1 |
1.0 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 |
1.2 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.3 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.2 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.6 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.4 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 |
1.0 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.4 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) metanephric distal tubule morphogenesis(GO:0072287) |
| 0.1 |
0.5 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 |
0.3 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.4 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 |
0.2 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 |
0.5 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
3.0 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
1.0 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.4 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
1.1 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 |
0.1 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.1 |
0.3 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.1 |
0.3 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.3 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.3 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
0.9 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.1 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.8 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.1 |
0.3 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 |
0.2 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.1 |
0.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.1 |
GO:0060775 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.1 |
1.2 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 0.1 |
0.2 |
GO:1905064 |
negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.1 |
0.3 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.4 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 |
0.1 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.1 |
0.6 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 |
0.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.1 |
1.2 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.7 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.2 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 |
0.3 |
GO:2000174 |
regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 |
0.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
0.3 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 |
0.7 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.2 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.1 |
0.2 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 |
0.5 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.2 |
GO:0060921 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
| 0.1 |
0.2 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.1 |
1.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.5 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.2 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.1 |
0.3 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 |
0.6 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.1 |
GO:0035050 |
embryonic heart tube development(GO:0035050) |
| 0.1 |
1.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 |
0.4 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
0.2 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.1 |
0.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.3 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.3 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.1 |
0.4 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 |
0.3 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.1 |
0.1 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.1 |
0.2 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.1 |
1.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.2 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 |
0.4 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
0.3 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.1 |
1.0 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.6 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.1 |
GO:0060676 |
ureteric bud formation(GO:0060676) |
| 0.1 |
0.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
0.1 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.1 |
0.2 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 |
0.2 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.2 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.1 |
0.1 |
GO:0060956 |
cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
| 0.1 |
0.9 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
0.1 |
GO:1990619 |
histone H3-K9 deacetylation(GO:1990619) |
| 0.1 |
0.4 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.2 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.1 |
0.1 |
GO:0033082 |
regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 |
0.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.2 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.5 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.9 |
GO:2000667 |
positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.1 |
0.2 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.3 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 |
0.2 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
0.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.1 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
1.1 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
2.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
4.5 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.4 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
0.2 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.9 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 |
0.3 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 |
0.2 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
0.2 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
1.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.3 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
0.1 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.1 |
0.8 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.1 |
0.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.2 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 |
0.2 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.1 |
0.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.7 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
0.2 |
GO:0045074 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.1 |
0.2 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
0.9 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.5 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
0.3 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.4 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.1 |
0.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.3 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.1 |
0.1 |
GO:0044257 |
cellular protein catabolic process(GO:0044257) |
| 0.1 |
0.4 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 |
0.3 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.1 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.1 |
0.9 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
1.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.3 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
0.4 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.7 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.1 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.1 |
1.2 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.2 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
0.3 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.1 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.1 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 |
0.2 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 |
0.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.3 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
0.2 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.2 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
2.0 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.5 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
0.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 |
0.3 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
0.6 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.3 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.1 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.1 |
0.2 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.1 |
0.1 |
GO:1903216 |
regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.1 |
0.3 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.1 |
0.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
0.4 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
0.6 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.1 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 |
1.0 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.1 |
0.2 |
GO:0061036 |
positive regulation of chondrocyte differentiation(GO:0032332) positive regulation of cartilage development(GO:0061036) |
| 0.1 |
0.3 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.1 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.1 |
0.1 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.1 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.4 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.1 |
0.4 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
1.0 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
0.2 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 |
0.1 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
0.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.9 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.9 |
GO:1904385 |
cellular response to angiotensin(GO:1904385) |
| 0.1 |
0.2 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
0.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.6 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.2 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 |
0.5 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.2 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 |
0.3 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.2 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
0.2 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 |
0.2 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.2 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.1 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.1 |
0.1 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.1 |
0.3 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
0.1 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
0.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
0.3 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.1 |
0.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.8 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
0.3 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.6 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
1.9 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.6 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.5 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.1 |
0.3 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.1 |
0.2 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
0.2 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.2 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.0 |
0.3 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 |
0.0 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.4 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.2 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 |
1.6 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.3 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.8 |
GO:0030825 |
positive regulation of cGMP metabolic process(GO:0030825) |
| 0.0 |
0.2 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.4 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.0 |
0.2 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.0 |
0.4 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.1 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.0 |
0.5 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.4 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.0 |
0.6 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.0 |
0.4 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.1 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.0 |
0.2 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.0 |
0.1 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) |
| 0.0 |
0.2 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
0.1 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.0 |
0.1 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 |
0.0 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.0 |
0.0 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.0 |
0.2 |
GO:0045978 |
negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.0 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.0 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.0 |
0.7 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.3 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 |
1.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.2 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.0 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.2 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.0 |
0.0 |
GO:0045778 |
positive regulation of ossification(GO:0045778) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.0 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.5 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.0 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.0 |
0.9 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 |
0.0 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 |
0.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.0 |
GO:0071106 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.2 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.0 |
0.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.1 |
GO:1900164 |
determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.0 |
0.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.0 |
0.1 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
1.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.3 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.4 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.2 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.8 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.2 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.0 |
0.1 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 |
0.3 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 |
0.2 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.0 |
0.2 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.0 |
0.1 |
GO:0034445 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.0 |
0.4 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.0 |
0.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.1 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.8 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.0 |
GO:0018199 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.5 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.0 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.0 |
0.0 |
GO:0022605 |
oogenesis stage(GO:0022605) |
| 0.0 |
0.0 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.1 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.0 |
0.2 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.0 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.1 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.0 |
0.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.0 |
0.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.0 |
0.0 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.0 |
0.1 |
GO:0060730 |
regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.0 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.0 |
0.2 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.0 |
0.2 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 |
0.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.4 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 |
0.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.0 |
0.1 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.0 |
0.2 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.4 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.1 |
GO:0038124 |
toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.0 |
0.2 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.1 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.0 |
0.1 |
GO:0032438 |
melanosome organization(GO:0032438) cellular pigmentation(GO:0033059) pigment granule organization(GO:0048753) |
| 0.0 |
0.7 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.5 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.7 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.1 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.0 |
0.1 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.0 |
0.2 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.1 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.0 |
0.1 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.0 |
0.3 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.0 |
1.0 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.0 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.2 |
GO:0001806 |
type IV hypersensitivity(GO:0001806) |
| 0.0 |
0.1 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.0 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.3 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 |
0.2 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 |
0.2 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.0 |
0.2 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.0 |
0.0 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
0.3 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.0 |
0.5 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.1 |
GO:0042634 |
regulation of hair cycle(GO:0042634) |
| 0.0 |
0.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.3 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 |
0.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.3 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.1 |
GO:0046203 |
spermidine catabolic process(GO:0046203) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.1 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.1 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.1 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.3 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.1 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.0 |
0.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.0 |
0.1 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.2 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.5 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.3 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.0 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
| 0.0 |
1.4 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.0 |
0.0 |
GO:0010666 |
positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.1 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.0 |
0.4 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.5 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.0 |
0.1 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 |
0.1 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.0 |
1.0 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 |
0.1 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 |
0.1 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 |
0.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.1 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.0 |
1.1 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.5 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.0 |
0.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.0 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.1 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.0 |
0.1 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 |
1.0 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.1 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.0 |
0.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.0 |
0.2 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.4 |
GO:0045732 |
positive regulation of protein catabolic process(GO:0045732) |
| 0.0 |
1.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.0 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.0 |
0.0 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.0 |
0.1 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.0 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.0 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 |
0.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 |
0.0 |
GO:0072162 |
metanephric mesenchymal cell differentiation(GO:0072162) |
| 0.0 |
2.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.7 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.1 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 |
0.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.3 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.0 |
0.3 |
GO:0015822 |
ornithine transport(GO:0015822) |
| 0.0 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.0 |
0.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.1 |
GO:0072070 |
proximal/distal pattern formation involved in nephron development(GO:0072047) loop of Henle development(GO:0072070) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.0 |
0.1 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.0 |
0.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.2 |
GO:0018904 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.2 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 |
0.2 |
GO:2000416 |
regulation of eosinophil migration(GO:2000416) |
| 0.0 |
0.1 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.0 |
0.0 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.3 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.0 |
0.1 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.2 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.3 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.0 |
0.5 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.0 |
0.1 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.0 |
0.0 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 0.0 |
0.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.0 |
1.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 |
0.2 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.0 |
0.2 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.0 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.0 |
0.2 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.0 |
0.4 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.0 |
0.2 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.0 |
0.9 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.1 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.4 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.0 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
1.2 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.0 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.0 |
GO:0009750 |
response to fructose(GO:0009750) |
| 0.0 |
0.1 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.3 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.1 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.0 |
0.8 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.0 |
0.5 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.7 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 |
0.3 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.1 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.8 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.1 |
GO:1900098 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) cellular response to fructose stimulus(GO:0071332) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
| 0.0 |
0.2 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.0 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.0 |
0.2 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.2 |
GO:1904721 |
negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.0 |
0.8 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
0.1 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.0 |
0.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.0 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.1 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.0 |
0.0 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.0 |
0.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 |
0.1 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 |
0.1 |
GO:0006174 |
dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) dGDP metabolic process(GO:0046066) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 |
0.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 |
0.1 |
GO:0002265 |
astrocyte activation involved in immune response(GO:0002265) |
| 0.0 |
0.0 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 |
0.1 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.2 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.0 |
2.8 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.4 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.2 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 |
0.1 |
GO:0051595 |
response to methylglyoxal(GO:0051595) |
| 0.0 |
0.1 |
GO:0071877 |
regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.0 |
1.5 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.1 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.9 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 |
0.3 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.0 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.2 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.0 |
0.1 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.8 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.1 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.0 |
0.0 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.0 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.1 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 |
0.1 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.0 |
0.1 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.0 |
0.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 |
0.1 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 |
0.2 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.5 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.3 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.2 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.0 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
0.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.3 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 |
0.1 |
GO:0048643 |
positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.0 |
0.0 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.0 |
0.1 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.2 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.1 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 |
0.2 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.1 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.2 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0072008 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) |
| 0.0 |
0.1 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.3 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.0 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.0 |
0.0 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.0 |
0.0 |
GO:0071035 |
nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.3 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.1 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.0 |
0.2 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.0 |
GO:0034443 |
regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.0 |
0.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.1 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.5 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.1 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 |
0.1 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.0 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.0 |
0.0 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.0 |
0.1 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.1 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.0 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.2 |
GO:0007622 |
rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.0 |
0.1 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.2 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.0 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.0 |
0.2 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.5 |
GO:0034204 |
lipid translocation(GO:0034204) |
| 0.0 |
0.5 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.0 |
GO:0060795 |
cell fate commitment involved in formation of primary germ layer(GO:0060795) |
| 0.0 |
0.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.0 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.1 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.5 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.0 |
0.0 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.0 |
0.0 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
1.2 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.0 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.0 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.0 |
GO:0043137 |
DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.0 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.0 |
0.2 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.0 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.0 |
0.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 |
0.1 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.1 |
GO:0021823 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) negative regulation of negative chemotaxis(GO:0050925) |
| 0.0 |
0.0 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 |
0.0 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
0.1 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.0 |
0.0 |
GO:0010906 |
regulation of glucose metabolic process(GO:0010906) |
| 0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.5 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.2 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
1.3 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.0 |
0.1 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.1 |
GO:0060356 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) leucine import(GO:0060356) |
| 0.0 |
0.1 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.1 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 |
0.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.2 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 |
0.3 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.0 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.0 |
1.1 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.3 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.0 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.1 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.0 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.0 |
0.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.0 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.1 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.1 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.0 |
0.0 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.0 |
0.0 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.0 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.1 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.1 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.0 |
0.0 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.0 |
0.3 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.1 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.0 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.2 |
GO:0098869 |
cellular oxidant detoxification(GO:0098869) |
| 0.0 |
0.1 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.0 |
GO:0046889 |
positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.0 |
0.0 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.0 |
0.1 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 |
0.3 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.0 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
0.0 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.1 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.0 |
0.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.0 |
0.4 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.0 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.0 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.0 |
0.1 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.0 |
0.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.0 |
0.3 |
GO:0006505 |
GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.0 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.1 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.1 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 |
0.0 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.0 |
GO:0021548 |
pons development(GO:0021548) |
| 0.0 |
0.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.0 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.0 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.0 |
0.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
0.0 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.7 |
GO:0021532 |
neural tube patterning(GO:0021532) |
| 0.0 |
2.4 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.4 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 |
0.1 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 |
0.1 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.0 |
0.0 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.0 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.0 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.0 |
0.3 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.0 |
GO:1903044 |
protein localization to membrane raft(GO:1903044) |
| 0.0 |
0.0 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 |
0.0 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.1 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.0 |
0.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
1.8 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.1 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.4 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.0 |
0.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
0.0 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.0 |
0.0 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.2 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.0 |
0.2 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.0 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.1 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.0 |
0.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.1 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.0 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
| 0.0 |
0.1 |
GO:0060369 |
positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 |
0.0 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
0.1 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.1 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.0 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.0 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.0 |
0.2 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.0 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.0 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.0 |
0.2 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0002304 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 |
0.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.1 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.1 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 |
0.2 |
GO:1900746 |
regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.0 |
GO:2000178 |
negative regulation of neural precursor cell proliferation(GO:2000178) |
| 0.0 |
0.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.0 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 |
0.2 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.0 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.0 |
0.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.0 |
0.1 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.0 |
GO:0014717 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.0 |
GO:0003207 |
cardiac chamber formation(GO:0003207) |
| 0.0 |
0.0 |
GO:2001169 |
regulation of ATP biosynthetic process(GO:2001169) |
| 0.0 |
0.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.0 |
GO:0060926 |
cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
| 0.0 |
0.1 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.0 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.0 |
0.0 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.0 |
0.1 |
GO:0036037 |
CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.0 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.0 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
0.1 |
GO:0043380 |
regulation of memory T cell differentiation(GO:0043380) |
| 0.0 |
0.7 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.1 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.3 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.1 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.0 |
0.2 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.1 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 |
0.0 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.0 |
0.1 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
| 0.0 |
0.1 |
GO:0060996 |
dendritic spine development(GO:0060996) |
| 0.0 |
0.4 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.0 |
GO:0002866 |
positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
| 0.0 |
0.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.0 |
0.0 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.1 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
1.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.1 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.0 |
0.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.2 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.0 |
0.1 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 |
0.0 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.1 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.0 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.1 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.1 |
GO:0034695 |
response to prostaglandin E(GO:0034695) |
| 0.0 |
0.1 |
GO:0030516 |
regulation of axon extension(GO:0030516) |
| 0.0 |
0.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.3 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.1 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 |
0.0 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.0 |
0.0 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.0 |
0.1 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 |
0.0 |
GO:0032753 |
positive regulation of interleukin-4 production(GO:0032753) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.0 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.2 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 |
0.0 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.0 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.0 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.0 |
0.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.0 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.0 |
GO:0060304 |
regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
| 0.0 |
0.0 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.0 |
0.1 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.0 |
GO:0048841 |
regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.0 |
1.4 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.1 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.0 |
0.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.0 |
0.2 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.1 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.1 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.3 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.1 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.0 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.0 |
GO:0048865 |
ganglion mother cell fate determination(GO:0007402) stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.0 |
0.0 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:0060897 |
neural plate regionalization(GO:0060897) |
| 0.0 |
0.1 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.0 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
